Finance & Crypto

Rojukis International - World Class Benchmarking

29 sec read9 views0 listens

Rojukis International, a Thai beauty and health company with a market cap of US$63 million, has achieved world-class benchmarking in profitability among small consumer staples companies globally. Its recent performance ranks second for profitability and fifth for growth, marking an improvement from previous periods.

This highlights Rojukis' strong financial management and steady growth trajectory, making it attractive to investors seeking stable returns in the Thai stock market.

Read the full article at Blog – Become a Better Investor

Want to create content about this topic? Use Nemati AI tools to generate articles, social posts, and more.

Wellness's Bet on Texas:

Texas is attracting significant investment from the wellness industry, which includes high-tech innovations and luxurious retreats. This trend matters to developers and tech professionals as it opens new opportunities for integrating technology in he...

Ali Nemati

Automotive & EV10 hours ago24 sec read

Audi CEO Admits New Flagship SUV Almost Got Those Electronic Door Handles Nobody Asked For

Audi CEO Gernot Döllner revealed that the company abandoned its plan to include electronic door handles in the 2027 Audi Q9, opting instead for conventional designs based on customer feedback. This decision underscores the importance of user-centric ...

Ali Nemati

Real Estate & Home11 hours ago23 sec read

Sydney woman's decade-long mould battle reveals threat to every home

A Sydney resident's long-term struggle with mould highlights the pervasive risk it poses to all homes, regardless of age or location. This issue is exacerbated by poor ventilation and high humidity, affecting health and property quality, underscoring...

Ali Nemati

Biotech & Pharma14 hours ago25 sec read

Evolutionarily Diverse Organisms Switch Genes on Simply and Switch Them off Dynamically

Researchers at the Centre for Genomic Regulation found that gene activation signals are remarkably consistent across two billion years of evolution, while silencing mechanisms vary widely among different life forms. This discovery could enhance medic...

Ali Nemati

Health & Medicine17 hours ago28 sec read

STAT+: Pharmalittle: We're reading about AstraZeneca-Bristol merger talks, a revised 340B plan, and more

AstraZeneca's stock fell by 5.5% as investors reacted negatively to reports of merger talks with Bristol Myers Squibb, potentially creating a $400 billion pharmaceutical giant. This development highlights investor skepticism about large-scale acquisi...

Ali Nemati

Rojukis International - World Class Benchmarking

Related Articles

Wellness's Bet on Texas:

Audi CEO Admits New Flagship SUV Almost Got Those Electronic Door Handles Nobody Asked For

Sydney woman's decade-long mould battle reveals threat to every home

Evolutionarily Diverse Organisms Switch Genes on Simply and Switch Them off Dynamically

STAT+: Pharmalittle: We're reading about AstraZeneca-Bristol merger talks, a revised 340B plan, and more